Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04743921 · ClinicalTrials.gov registry record · NA

Effects of Reparel™ Knee Sleeve on Knee Osteoarthritis

A NA study, sponsored by University of Alabama at Birmingham.

Completed
Registry status
NA
Development phase
14
Enrollment target

NCT04743921 is a NA study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 14 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04743921, a NA study, has completed, sponsored by University of Alabama at Birmingham.

COMPLETED
Registry status
NA
Development phase
14 participants
Enrollment target

Study Summary

The goals of treating knee osteoarthritis (OA) is to improve or maintain quality of life, mobility and function, pain relief, and improve inflammation. The different treatment options for knee OA have been extensively studied and implemented, but the optimum treatment is still undecided. There is a belief that anti-inflammatory sleeve technology may be beneficial in treating knee OA. The purpose of this study is to determine the clinical effects of Reparel™ knee sleeve regarding mobility, functionality, and pain outcomes in managing knee OA.

Interventions

  • DEVICE Reparel Knee Sleeve

Trial Details

FieldValue
Enrollment Target 14 participants
Start Date 2021-02-01
Est. Completion 2021-11-06
Phase NA

Sponsor

University of Alabama at Birmingham

1,160 total trials

What the Registry Record Tells You About NCT04743921

The ClinicalTrials.gov registry entry for NCT04743921 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Reparel Knee Sleeve is the first listed.

NCT04743921 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04743921 about?

NCT04743921 is a clinical study titled "Effects of Reparel™ Knee Sleeve on Knee Osteoarthritis". The goals of treating knee osteoarthritis (OA) is to improve or maintain quality of life, mobility and function, pain relief, and improve inflammation. The different treatment options for knee OA have been extensively studied and implemented, but the optimum treatment is still undecided. There is a be...

What is the current status of trial NCT04743921?

This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2021-02-01. Estimated completion is 2021-11-06.

What interventions are being tested in trial NCT04743921?

The interventions under investigation include: Reparel Knee Sleeve (DEVICE).

Who is sponsoring clinical trial NCT04743921?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.